Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Gross Margin (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Gross Margin for 13 consecutive years, with 8070.36% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 812607.0% year-over-year to 8070.36%, compared with a TTM value of 75.6% through Dec 2025, up 2353.0%, and an annual FY2025 reading of 6905.45%, down 695752.0% over the prior year.
  • Gross Margin was 8070.36% for Q4 2025 at Tandem Diabetes Care, down from 53.88% in the prior quarter.
  • Across five years, Gross Margin topped out at 55.71% in Q4 2024 and bottomed at 8070.36% in Q4 2025.
  • Average Gross Margin over 5 years is 354.51%, with a median of 51.44% recorded in 2022.
  • The sharpest move saw Gross Margin soared 830bps in 2024, then crashed -812607bps in 2025.
  • Year by year, Gross Margin stood at 54.16% in 2021, then dropped by -3bps to 52.39% in 2022, then decreased by -10bps to 47.41% in 2023, then increased by 18bps to 55.71% in 2024, then plummeted by -14587bps to 8070.36% in 2025.
  • Business Quant data shows Gross Margin for TNDM at 8070.36% in Q4 2025, 53.88% in Q3 2025, and 52.29% in Q2 2025.